You just read:

Synthetic Biologics Announces Completion of End of Phase 2 Meeting with FDA for SYN-010, Intended for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)

News provided by

Synthetic Biologics, Inc.

Aug 02, 2016, 06:58 ET